These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29911550)

  • 1. [Current status of the French National Data Repository in the field of Rare Diseases].
    Salamanca E
    Med Sci (Paris); 2018 May; 34 Hors série n°1():26. PubMed ID: 29911550
    [No Abstract]   [Full Text] [Related]  

  • 2. [State of play of French data collections in the field of rare diseases].
    Aymé S
    Med Sci (Paris); 2018 May; 34 Hors série n°1():22-25. PubMed ID: 29911549
    [No Abstract]   [Full Text] [Related]  

  • 3. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inaugural conference - what stakes face rare diseases in the French health care system].
    Péton-Klein D
    Med Sci (Paris); 2014 Apr; 30 Spe(1):5-7. PubMed ID: 24755170
    [No Abstract]   [Full Text] [Related]  

  • 5. [Not Available].
    Dollfus H
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():5-7. PubMed ID: 27137853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Not Available].
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():23-8. PubMed ID: 27137858
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of a national administrative database to guide public decisions: From the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France.
    Tuppin P; Rudant J; Constantinou P; Gastaldi-Ménager C; Rachas A; de Roquefeuil L; Maura G; Caillol H; Tajahmady A; Coste J; Gissot C; Weill A; Fagot-Campagna A
    Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S149-S167. PubMed ID: 28756037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What place for French morbidity registries in the era of big data?].
    Francis F; Terroba C; Persoz C; Gagliolo JM; Alla F
    Rev Epidemiol Sante Publique; 2020 Apr; 68(2):117-123. PubMed ID: 31974001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Italian National Rare Diseases Registry.
    Taruscio D; Kodra Y; Ferrari G; Vittozzi L;
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s606-13. PubMed ID: 24922301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH/NCATS/GRDR® Common Data Elements: A leading force for standardized data collection.
    Rubinstein YR; McInnes P
    Contemp Clin Trials; 2015 May; 42():78-80. PubMed ID: 25797358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for national registries for rare endocrine tumor syndromes.
    Leeuwaarde RSV; Herder WW; Valk GD
    Endocrine; 2017 Nov; 58(2):205-206. PubMed ID: 28417312
    [No Abstract]   [Full Text] [Related]  

  • 12. [Introduction and welcome message].
    Schwebig A; Levy N; Ayme S
    Presse Med; 2012 May; 41 Suppl 1():S1-2. PubMed ID: 22483772
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicentre clinical registries. Establishment of multicentre clinical registries as a basis for comparative evaluation of rare diseases.
    Martus P
    Adv Exp Med Biol; 2003; 528():17-24. PubMed ID: 12918654
    [No Abstract]   [Full Text] [Related]  

  • 14. Data Quality in Rare Diseases Registries.
    Kodra Y; Posada de la Paz M; Coi A; Santoro M; Bianchi F; Ahmed F; Rubinstein YR; Weinbach J; Taruscio D
    Adv Exp Med Biol; 2017; 1031():149-164. PubMed ID: 29214570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for the European platform for rare disease registries.
    Vittozzi L; Gainotti S; Mollo E; Donati C; Taruscio D
    Public Health Genomics; 2013; 16(6):299-304. PubMed ID: 24503590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of algorithms to identify incident cancer cases by using French health administrative databases.
    Ajrouche A; Estellat C; De Rycke Y; Tubach F
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):935-944. PubMed ID: 28485129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Round table 1. PNMR 2011-2014: point of view of the stakeholders].
    Med Sci (Paris); 2014 Apr; 30 Spe(1):8-13. PubMed ID: 24755171
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview of patients' cohorts in the French National rare disease registry.
    Pichon T; Messiaen C; Soussand L; Angin C; Sandrin A; Elarouci N; Jannot AS;
    Orphanet J Rare Dis; 2023 Jul; 18(1):176. PubMed ID: 37400917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focusing on rare diseases in China: are we there yet?
    Yang L; Su C; Lee AM; Bai HX
    Orphanet J Rare Dis; 2015 Nov; 10():142. PubMed ID: 26525984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing Data at the Source to Foster Interoperability across Rare Disease Resources.
    Roos M; López Martin E; Wilkinson MD
    Adv Exp Med Biol; 2017; 1031():165-179. PubMed ID: 29214571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.